This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
ABBV-744 (AbbVie oral in vivo BD2 domain selective BET inhibitor)
molecule
2 years ago ●
1 min read
AG-881 (vorasidenib)Â (Agios oral brain penetrant allosteric mutant IDH1/2 dual inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
FT-2102 (olutsidenib) (FORMA oral allosteric mutant-selective IDH1 inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
GS-9876 (lanraplenib) (Gilead Sciences oral SYK selective kinase inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
KRAS(G12C) inhibitor from AZ (AstraZeneca oral in vivo mutant KRAS(G12C) allosteric covalent inhibitor)
molecule
2 years ago ●
1 min read
RORγt inhibitor from Merck (Merck ROR-gamma-t oral in vivo allosteric inhibitor)
molecule
2 years ago ●
1 min read
Load More
